Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Network Clinical Trials Quality Assurance

As a sponsor and funding agency for cancer clinical trials, DCTD is required by FDA regulations to maintain a Quality Assurance program. This program includes auditing and monitoring. CTEP's Clinical Trials Monitoring Branch (CTMB) oversees monitoring and auditing of all CTEP-sponsored clinical trials, as well as select studies sponsored by the Division of Cancer Prevention (DCP). The below resources provide more information on the auditing and monitoring process.

If you have questions or to report concerns about research misconduct, please contact CTMB at one of the following email addresses:

Auditing and Monitoring Guidelines

NCTN and NCORP Auditing Guidelines

ETCTN and Early Phase CTMS-Monitored Studies

Good Clinical Practice (GCP) Guidelines

International Council for Harmonisation (ICH) Efficacy Guideline for GCP

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Network Clinical Trials Quality Assurance was originally published by the National Cancer Institute.”

Email